

CLASSIFICATION: IMMUNOMODULATORY PEPTIDE BIOREGULATOR
ACTIVE SUBSTANCE: THYMAGEN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 20 MG)
ACTIVE HALF-LIFE: APPROX. 4–6 HOURS
DOSAGE: 10–20 MG PER WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
Thymagen is a short-chain synthetic peptide derived from thymus gland proteins, offered here in a 20 mg (2 mL) vial formulation by Peptide Hubs. Designed for research use only, Thymagen is studied for its ability to regulate immune responses, improve thymic activity, and promote cellular regeneration in immune-deficient or aging models. It belongs to the class of peptide bioregulators that target specific organs or tissues for regenerative and anti-aging outcomes.
Thymagen consists of a naturally occurring peptide fragment found in thymic extract, known for its role in promoting T-cell differentiation and restoring immunological function. Its most promising applications are seen in aging research, recovery from immunosuppression, and modulation of chronic inflammatory states. As detailed in scientific literature, thymic peptides have shown promise in enhancing immune system balance and homeostasis.
Thymagen is typically used in research protocols at doses of 10–20 mg per week, delivered via subcutaneous injection. Studies often last between 10 and 30 days depending on the intended scope – such as immune restoration, post-illness recovery, or anti-aging investigations. The peptide has a relatively short half-life, which promotes efficient systemic action when administered consistently over time.
To enhance results, researchers often combine Thymagen with other regenerative or immune-focused peptides, including:
Thymagen has demonstrated an excellent safety profile in animal studies and early human trials (non-FDA-approved). It does not influence hormonal levels, and there are no reported cases of hepatotoxicity or blood pressure elevation. The peptide is well tolerated and rapidly metabolized. Mild injection site reactions may occur but are usually self-limiting.
Peptide Hubs ensures USA domestic shipping for Thymagen 20 mg, with all orders processed discreetly and professionally. This research-grade peptide is manufactured under strict GMP guidelines. For broader immunomodulatory protocols, researchers may explore synergistic stacking with AOD 9604 or SS-31 to support mitochondrial and systemic recovery.
Thymagen is studied for its ability to restore thymus gland activity, enhance T-cell development, and support immune system balance in aging or immunocompromised models.
Yes, it has a strong safety profile and does not interact with hormones, liver, or kidneys in preclinical studies.
Doses between 10–20 mg per week are used in most research protocols, often divided into multiple injections across 2–4 weeks.
Yes, Thymagen is frequently stacked with Thymosin Alpha-1, GHK-Cu, or CJC-1295 no DAC in anti-aging or immune-centric studies.
Please log in to write THYMAGEN 20 MG review.
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: 2 ML VIAL (30 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–5 HOURS
DOSAGE: 200–500 MCG ONCE OR TWICE DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS